Top Markets
Coin of the day
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc.

AOBI
Kedudukan dalam Saham #42790
American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China,... American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China, focuses its operations on the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical and healthcare products. The company's core pharmaceutical offerings include a range of prescription medications. Among these are the Shuanghuanglian Lyophilized Injection Powder (SHL brand), prescribed to treat flu symptoms such as elevated fever, coughs, and sore throats, as well as to address upper respiratory tract infections, mild pneumonia, bronchitis, and tonsillitis. Another significant prescription product is the Cease Enuresis Soft Gel (CE Gel brand), formulated to alleviate bedwetting. AOBI's portfolio also extends to various over-the-counter (OTC) pharmaceutical solutions. These feature the Cease Enuresis Patch for managing bedwetting and urinary incontinence; Jinji Capsule, used for conditions like endometritis, annexitis, and pelvic inflammations; Jinji Yimucao, designed to relieve premenstrual syndrome (PMS) and other related menstrual and menopausal discomforts; and Boke Nasal Spray, which offers relief for sinus congestion associated with the common cold, nasal stuffiness, chronic rhinitis, allergic rhinitis, and nasosinusitis. Furthermore, the company develops and markets a selection of nutraceutical products, notably including soybean peptide-based items available as beverages, tablets, powders, and instant coffee. Beyond its manufacturing activities, AOBI is also involved in the wholesale and retail distribution of both its pharmaceutical and nutraceutical goods. The company's products are sold across the People's Republic of China through both direct channels and a network of distributors, reaching hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical retailers, and various other retail outlets.
Harga Saham
$0.0012
Disegerakkan terakhir: 2026-08-11
Modal Pasaran
$88.00
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
140.00%
Negara
CN
Perdagangan American Oriental Bioengineering, Inc. (AOBI)

Kategori

Harga AOBI dengan permodalan pasaran b
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
AOBI
$0.0012
Modal pasaran bagi American Oriental Bioengineering, Inc.(AOBI)
Modal Pasaran: $88.00
Sehingga August 2026, American Oriental Bioengineering, Inc. mempunyai modal pasaran sebanyak $88.00. Ini menjadikan American Oriental Bioengineering, Inc. syarikat ke-42790th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran American Oriental Bioengineering, Inc. dari 2001 hingga 2026
AOBI berbanding dengan 5 teratas yang paling popular stocks
Harga AOBI Aset B Pasaran B Hasilnya
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$73,991,089 $88.00
$5.426T +6,165,924,076,240.12%
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$60,503,503 $88.00
$4.437T +5,041,958,570,211.68%
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$56,582,799 $88.00
$4.149T +4,715,233,259,327.32%
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$49,961,690 $88.00
$3.664T +4,163,474,181,032.64%
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$39,399,036 $88.00
$2.889T +3,283,252,979,459.00%